Active Pharmaceutical Ingredients

ACTIVE PHARMACEUTICAL INGREDIENTS (APIs)

PRODUCT SPECIFICATION THERAPEUTIC CATEGORY TECH PACK DMF APPROVAL
Sertraline HCI USP/EP CNS Available Available CEP/ EU-WC
Racecadotril EP Anti Diarrhea Available Available CEP/EU-WC
Palonosetron HCI USP/IHS Anti Emetic Available Available USFDA/ EU-WC
Silodosin IHS Benign Prostatic Hypertrophy Available Available EU-WC
Solifenacin Succinate EP/IHS Urinary Incontinence Available Available EU-WC/ CEP-Applied
Tamsulosin HCI EP/USP Benign Prostatic Hypertrophy Available Available EU-WC/ CEP-Q3-2020
Tenofovir Disoproxil Fumarate USP/IHS Anti Retroviral Available Available EU-WC
Tenofovir Alafenamide Fumarate IHS Anti Retroviral Available Available -
Atazanavir IHS Anti Retroviral Available Available -
Rupatadine Fumarate EP/IHS Anti Histamine Available Available EU-WC/ CEP- Applied
Glucosamine HCI USP/EP Anti Arthritic Available Available EU-WC
Glucosamine Sulfate KCL USP Anti Arthritic Available Available EU-WC
Glucosamine Sulfate NaCl USP/EP Anti Arthritic Available Available EU-WC
Nitrofurantoin Monohydrate USP Anti microbial Available Under Preparation -
Nitrofurantoin Anhydrous USP/EP Anti microbial Available Under Preparation CEP- Q4 2020
Nitrofurantoin Macrocrystal USP/EP Anti microbial Available Under Preparation CEP- Q4 2020

Active Pharmaceutical Ingredients (Under Development)

PRODUCT Cinacalcet THERAPEUTIC CATEGORY Anti Hyperparathyroid
Felbamate Anti Convulsant
Zileuton Antiasthmatic
Pramiracetam CNS Stimulant & Nootropic Agent

Disclaimer: Products covered by valid patents are not offered for commercial use. It is the responsibility of buyers to ensure transactions do not infringe any patent rights applicable.